IBM Watson Health, Aetion partner to advance biopharma research

IBM Watson Health, Aetion partner to advance biopharma research

Publication date: Nov 04, 2019

IBM Watson Health and Aetion codeveloped a tool enabling small and mid-size biopharmaceutical companies to conduct advanced data analysis of real-world evidence to evaluate the safety and effectiveness of new medical treatments.

Concepts Keywords
Biopharmaceutical IBM
IBM Watson Informatics General
Watson
Digital technology
Companies
Mid size biopharmaceutical
Computing

Semantics

Type Source Name
disease DOID INCLUSION BODY MYOSITIS
disease MESH INCLUSION BODY MYOSITIS

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *